Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 372, Issue 4, 2008, Pages 845-849

  Shama, Jessica ^a   Garcia Medina, Raquel ^a   Pouysségur, Jacques ^a   Vial, Emmanuel ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Colon adenocarcinoma; ERK1; ERK2; Growth; MAP kinases; MEK1; MEK2; RNAi

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; SHORT HAIRPIN RNA;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; COLON CARCINOMA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; ENZYME ACTIVATION; HUMANS; MALE; MAP KINASE KINASE 1; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS;

MAMMALIA;

EID: 45449107756     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.135     Document Type: Article

References (25)

1. Lewis T.S., Shapiro P.S., and Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74 (1998) 49-139
2. Schaeffer H.J., and Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19 (1999) 2435-2444
3. Meloche S., and Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26 (2007) 3227-3239
4. Sturgill T.W. MAP kinase: it's been longer than fifteen minutes. Biochem. Biophys. Res. Commun. 371 (2008) 1-4
5. Marais R., Wynne J., and Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73 (1993) 381-393
6. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351 (1996) 127-134
7. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 49 (1989) 4682-4689
8. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A., Nicholson A., Ho J.W., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R., Marshall C.J., Wooster R., Stratton M.R., and Futreal P.A. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
9. Sebolt-Leopold J.S., Dudley D.T., Herrera R., Van Becelaere K., Wiland A., Gowan R.C., Tecle H., Barrett S.D., Bridges A., Przybranowski S., Leopold W.R., and Saltiel A.R. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5 (1999) 810-816
10. Kohno M., and Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann. Med. 38 (2006) 200-211
11. Pages G., Lenormand P., L'Allemain G., Chambard J.C., Meloche S., and Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90 (1993) 8319-8323
12. Lavoie J.N., L'Allemain G., Brunet A., Muller R., and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271 (1996) 20608-20616
13. Kerkhoff E., and Rapp U.R. Cell cycle targets of Ras/Raf signalling. Oncogene 17 (1998) 1457-1462
14. Enslen H., and Davis R.J. Regulation of MAP kinases by docking domains. Biol. Cell. 93 (2001) 5-14
15. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351 (2000) 289-305
16. Belanger L.F., Roy S., Tremblay M., Brott B., Steff A.M., Mourad W., Hugo P., Erikson R., and Charron J. Mek2 is dispensable for mouse growth and development. Mol. Cell. Biol. 23 (2003) 4778-4787
17. Giroux S., Tremblay M., Bernard D., Cardin-Girard J.F., Aubry S., Larouche L., Rousseau S., Huot J., Landry J., Jeannotte L., and Charron J. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr. Biol. 9 (1999) 369-372
18. Scholl F.A., Dumesic P.A., and Khavari P.A. Mek1 alters epidermal growth and differentiation. Cancer Res. 64 (2004) 6035-6040
19. Ussar S., and Voss T. MEK1 and MEK2 different regulators of the G1/S transition. J. Biol. Chem. 279 (2004) 43861-43869 Epub 4, 2004 July 43828.
20. Liu X., Yan S., Zhou T., Terada Y., and Erikson R.L. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23 (2004) 763-776
21. Xu S., Khoo S., Dang A., Witt S., Do V., Zhen E., Schaefer E.M., and Cobb M.H. Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism. Mol. Endocrinol. 11 (1997) 1618-1625
22. Lenormand P., Sardet C., Pages G., L'Allemain G., Brunet A., and Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122 (1993) 1079-1088
23. van de Wetering M., Oving I., Muncan V., Pon Fong M.T., Brantjes H., van Leenen D., Holstege F.C., Brummelkamp T.R., Agami R., and Clevers H. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4 (2003) 609-615
24. Gayet J., Zhou X.P., Duval A., Rolland S., Hoang J.M., Cottu P., and Hamelin R. Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20 (2001) 5025-5032
25. Lefloch R., Pouysségur J., and Lenormand P. Single and combined ERK1/ERK2 silencing reveals their positive contribution to growth signaling depending on their expression levels. Mol. Cell. Biol. 28 (2008) 511-527